Are Current Cancer Treatments on Target for Our Ageing Cancer Population?

Mark Baxter (Lead / Corresponding author), Kwok-Leung Cheung, Nicolò Matteo Luca Battisti

    Research output: Contribution to journalComment/debatepeer-review

    20 Downloads (Pure)

    Abstract

    Worldwide the cancer population is ageing – within a decade almost two-thirds of newly diagnosed patients will be aged 65 years and older. Despite this, the majority of oncology clinical trials continue to recruit patients who are younger and fitter than those typically encountered in clinical practice. As such, there is a lack of clinical data to guide management, particularly in those patients living with frailty and/or comorbidity. Importantly, the lack of older adults in trials also means that the subsequent translational work that underpins biomarker and therapeutic discovery may not be relevant to those we see in clinic. In this commentary, we discuss this challenge and the ways we as an Oncology community can look to address this pressing issue.
    Original languageEnglish
    Article number63
    Number of pages5
    JournalAgeing and Cancer Research & Treatment
    Volume1
    Issue number1
    DOIs
    Publication statusPublished - 30 Jun 2023

    Fingerprint

    Dive into the research topics of 'Are Current Cancer Treatments on Target for Our Ageing Cancer Population?'. Together they form a unique fingerprint.

    Cite this